Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
The main target organ for hepatitis C virus (HCV) is the liver, but it has been clinically reported to cause lesions in tissues other than the liver. In this study, we showed that liver-specific microRNAs other than miR-122 can contribute to the enhancement of HCV-RNA replication in the process of persistent HCV infection in non-liver cells. In addition, the various miRNAs obtained in this study interact with the 5'UTR of HCV-RNA to enhance the stability of not only the secondary structure but also the tertiary structure of the active IRES structure, which leads to enhanced translation and replication. It turned out to be important.
|